Monday, October 19, 2015

Naia Limited Gets $5.3M

Richmond, California-based Naia Limited, which is developing treatments for short bowel syndrome (SBS), non-alcoholic steatohepatitis (NASH) and Type 2 diabetes, said this morning that it has raised $5.3M in a Series A financing round. The funding was led by Pharco Pharmaceuticals and The Trout Group. Naia is led by H. Daniel Perez, M.D.